These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10487677)

  • 1. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
    Landstedt-Hallin L; Adamson U; Lins PE
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3140-5. PubMed ID: 10487677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
    Peacey SR; Rostami-Hodjegan A; George E; Tucker GT; Heller SR
    J Clin Endocrinol Metab; 1997 May; 82(5):1458-61. PubMed ID: 9141533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
    Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
    Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
    El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4165-71. PubMed ID: 17698900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.
    Liu D; Moberg E; Kollind M; Lins PE; Adamson U
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
    Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
    Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
    Tuomi T; Honkanen EH; Isomaa B; Sarelin L; Groop LC
    Diabetes Care; 2006 Feb; 29(2):189-94. PubMed ID: 16443858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus.
    Landstedt-Hallin L; Englund A; Adamson U; Lins PE
    J Intern Med; 1999 Sep; 246(3):299-307. PubMed ID: 10475998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
    Østergård T; Degn KB; Gall MA; Carr RD; Veldhuis JD; Thomsen MK; Rizza RA; Schmitz O
    J Clin Endocrinol Metab; 2004 Jan; 89(1):297-302. PubMed ID: 14715864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
    Rossetti P; Porcellati F; Busciantella Ricci N; Candeloro P; Cioli P; Nair KS; Santeusanio F; Bolli GB; Fanelli CG
    Diabetes; 2008 Jul; 57(7):1905-17. PubMed ID: 18390791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
    Joy NG; Tate DB; Davis SN
    Metabolism; 2015 Jun; 64(6):729-37. PubMed ID: 25765720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
    Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
    Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects.
    Rasmussen BM; Orskov L; Schmitz O; Hermansen K
    Metabolism; 2001 Apr; 50(4):451-7. PubMed ID: 11288041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.